Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Capital Employed (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Return on Capital Employed for 15 consecutive years, with 0.07% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 4.0% to 0.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07% through Dec 2025, down 4.0% year-over-year, with the annual reading at 0.06% for FY2025, 4.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.07% at Anika Therapeutics, up from 0.07% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.09% in Q3 2024, with the low at 0.11% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.02%, with a median of 0.02% recorded in 2021.
  • The sharpest move saw Return on Capital Employed fell -21bps in 2021, then grew 12bps in 2024.
  • Over 5 years, Return on Capital Employed stood at 0.01% in 2021, then skyrocketed by 40bps to 0.01% in 2022, then plummeted by -73bps to 0.0% in 2023, then crashed by -937bps to 0.03% in 2024, then plummeted by -150bps to 0.07% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.07%, 0.07%, and 0.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.